Suresh K Balasubramanian
Overview
Explore the profile of Suresh K Balasubramanian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
521
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kewan T, Bahaj W, Gurnari C, Ogbue O, Mukherjee S, Advani A, et al.
Leukemia
. 2024 Jul;
38(9):2032-2036.
PMID: 39020062
No abstract available.
2.
Kewan T, Durmaz A, Bahaj W, Gurnari C, Terkawi L, Awada H, et al.
Nat Commun
. 2024 Feb;
15(1):1184.
PMID: 38332139
No abstract available.
3.
Bahaj W, Kewan T, Gurnari C, Durmaz A, Ponvilawan B, Pandit I, et al.
J Hematol Oncol
. 2023 Aug;
16(1):91.
PMID: 37537667
Background: TP53 mutations (TP53) occur in diverse genomic configurations. Particularly, biallelic inactivation is associated with poor overall survival in cancer. Lesions affecting only one allele might not be directly leukemogenic,...
4.
Kewan T, Durmaz A, Bahaj W, Gurnari C, Terkawi L, Awada H, et al.
Nat Commun
. 2023 May;
14(1):3136.
PMID: 37253784
Genomic mutations drive the pathogenesis of myelodysplastic syndromes and acute myeloid leukemia. While morphological and clinical features have dominated the classical criteria for diagnosis and classification, incorporation of molecular data...
5.
Bahaj W, Kewan T, Gurnari C, Durmaz A, Ponvilawan B, Pandit I, et al.
Res Sq
. 2023 Mar;
PMID: 36945617
mutations ( ) occur in diverse genomic configurations. Particularly, biallelic inactivation is associated with poor overall survival in cancer. Lesions affecting only one allele might not be directly leukemogenic, questioning...
6.
Balasubramanian S, Sharma M, Venur V, Schmitt P, Kotecha R, Chao S, et al.
Neuro Oncol
. 2019 Oct;
22(2):267-277.
PMID: 31648302
Background: The impact of activating alterations in non-small cell lung cancer (NSCLC) (epidermal growth factor receptor [EGFR] mutation/anaplastic lymphoma kinase [ALK] translocation) in prognosticating patients with brain metastasis (BM) is...
7.
Aly M, Ramdzan Z, Nagata Y, Balasubramanian S, Hosono N, Makishima H, et al.
Blood Adv
. 2019 Jul;
3(14):2164-2178.
PMID: 31320321
Somatic mutations of the CUT-like homeobox 1 () gene ( ) can be found in myeloid neoplasms (MNs), in particular, in myelodysplastic syndromes (MDSs). The locus is also deleted in...
8.
Maciejewski J, Balasubramanian S
Hematology Am Soc Hematol Educ Program
. 2017 Dec;
2017(1):66-72.
PMID: 29222238
Recent technological advances in genomics have led to the discovery of new somatic mutations and have brought deeper insights into clonal diversity. This discovery has changed not only the understanding...
9.
Bat T, Abdelhamid O, Balasubramanian S, Mai A, Radivoyevitch T, Clemente M, et al.
Br J Haematol
. 2017 Aug;
182(5):730-733.
PMID: 28804905
No abstract available.
10.
Magnuson W, Lester-Coll N, Wu A, Yang T, Lockney N, Gerber N, et al.
J Clin Oncol
. 2017 Jan;
35(10):1070-1077.
PMID: 28113019
Purpose Stereotactic radiosurgery (SRS), whole-brain radiotherapy (WBRT), and epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) are treatment options for brain metastases in patients with EGFR-mutant non-small-cell lung cancer (NSCLC)....